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Abstract:  Equisetum arvense, commonly known as the field horsetail, has potential as a new functional food ingredient.
However, little information is available on its side effects, and the general toxicity of Equisetum arvense has yet to be
examined in detail.  In the present study, we evaluated the influence of administration in diet at doses of 0, 0.3, 1 and
3% for 13 weeks in male and female F344 rats.  No toxicity was detected with reference to clinical signs, body weight,
urinalysis, hematology and serum biochemistry data and organ weights.  Microscopic examination revealed no
histopathological lesions associated with treatment.  In conclusion, the no-observed-adverse-effect level (NOAEL) for
Equisetum arvense was determined to be greater than 3% in both sexes of F344 rat (males and females: >1.79 g/kg BW/
day and >1.85 g/kg BW/day, respectively) under the conditions of the present study.  (J Toxicol Pathol 2010; 23: 245–
251)
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Introduction
Equisetum arvense, commonly known as the field
horsetail, is a bushy perennial featuring rhizomatous stem
formation1.  The plant contains abundant minerals such as
silicon and calcium2, as well as small amounts of pharmaco-
logically active compounds, and has been used as a tradi-
tional medicine to stop bleeding, heal ulcers and wounds and
treat tuberculosis and kidney diseases.  It is available as a
dried extract in powdered form or a liquid extract, and its
biological effects include anti-oxidant3, 4, anti-convulsant
and sedative actions5, as demonstrated in recent in vitro and
in vivo studies.  In particular, it is expected to lower high
blood pressure due to its diuretic effect, which was previ-
ously observed in rats and humans6.  Therefore, Equisetum
arvense may have potential as new functional food ingredi-
ent. 
Recently, no genetic toxicity of Equisetum arvense was
reported in a reverse mutation test, chromosomal aberration
test or micronucleus test7.  Additionally, the LD50 value of
Equisetum arvense was found to exceed 5000 mg/kg in a sin-
gle-dose toxicity study in rats7. 
However, it was reported to cause skin dermatitis in
people allergic to tobacco smoke8.  Furthermore, little is
known about its side effects when continuously administered
via the oral route.
In the present study, we therefore examined the general
toxicity of Equisetum arvense administered in diet for 13
weeks to male and female F344 rats. 
Materials and Methods
Animals and test chemical
Five-week-old F344 rats (40 males and 40 females)
were obtained from Charles River Laboratories Japan, Inc.
(Kanagawa, Japan) and housed in a room maintained under a
12-h light/dark cycle at constant temperature (23 ± 1°C) and
humidity (50 ± 5%).  Test chemicals (Lot.183-3194G, Cross
Co., Ltd., Osaka, Japan), a yellow-green to yellow fresh
powder, were prepared every month from Equisetum
arvense, extracted with hot water and mixed with powdered
CRF-1 basal diet (Oriental Yeast, Tokyo, Japan) at each con-
centration.  The diet of each group was changed twice a
week during the experiment.
Experimental design
All procedures were approved by the Institutional Ani-
mal Care and Use Committee of Osaka City University Med-
ical School.  After acclimation for 1 week, male and female
rats at six weeks of age were randomly divided into eight
groups of 10 rats each.  Dosage selections were based on
estimated intake for humans as follows.  We expected that
people consumed 5 mg/kg Equisetum arvense daily as a sup-
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plement.  To ensure a safety factor of 100-fold, the 1% dose
was set to feed at an approximate dosage level of 500 mg/kg,
and 3 and 0.3% doses were chosen as the high and low dose
groups using a common ratio of about 3.  The animals
received diets containing Equisetum arvense at doses of 0,
0.3, 1 and 3%, respectively, for 13 weeks.  They were
observed daily for clinical signs and mortality.  Body weight
and food consumption were measured weekly.  Fresh urine
samples were collected from all animals at week 13.  Urinal-
ysis using N-multistix SG-L and Clinitek Status (Siemens,
Tokyo, Japan) was performed for the following parameters:
glucose (GLU), bilirubin (BIL), ketone (KET), specific
gravity (SG), protein (PRO), urobilinogen (URO), occult
blood (OB), pH and nitrite (NIT).  At the end of the experi-
ment, all animals were fasted overnight and euthanized by
exsanguination under ether anesthesia.  Blood was taken
from the abdominal aorta for hematology and serum bio-
chemistry analyses.  Hematological examinations included
the following parameters: white blood cell count (WBC), red
blood cell count (RBC), hemoglobin concentration (Hb),
hematocrit (Ht), platelet count (PLT), mean corpuscular vol-
ume (MCV), mean corpuscular hemoglobin (MCH) and
mean corpuscular hemoglobin concentration (MCHC).
Serum biochemistry was performed to examine total pro-
teins (TP), albumin (ALB), albumin/globulin ratio (A/G),
aspartate aminotransferase (AST), alanine aminotransferase
(ALT), alkaline phosphatase (ALP), gamma glutamyl
transpeptidase (γ-GTP), creatinine (CRN), triglycerides
(TG), total cholesterol (T-Cho), total bilirubin (T-Bil), blood
urea nitrogen (BUN), sodium (Na), potassium (K), chloride
(Cl), calcium (Ca) and inorganic phosphorus (P).  Analyses
for hematology and serum biochemistry were conducted at
Mitsubishi Chemical Medience Corp., (Osaka, Japan) using
automatic analyzing machines, XT-2100 (Sysmex, Hyogo,
Japan) and H7700 (Hitachi, Tokyo, Japan), for blood and
serum analyses, respectively.  At sacrifice, the heart, liver,
spleen, kidneys, adrenals, testes, brain and thymus were
excised and weighed.  In addition to these organs, the lymph
nodes (cervical and mesenteric), aorta, salivary gland, bone
(sternum, femur), bone marrow, trachea, thyroid, tongue,
esophagus, stomach, duodenum, small intestine, large intes-
tine, pancreas, urinary bladder, seminal vesicles, prostate
gland, epididymis, ovaries, uterus, vagina, pituitary gland,
sciatic nerve, skeletal muscle, spinal cord, eyes and harde-
rian glands were excised and fixed in 10% buffered formalin.
Testes were fixed in Bouin's solution.  Paraffin-embedded
tissue sections of all organs and tissues were routinely pre-
pared and stained with hematoxylin and eosin for histopatho-
logical examination.  All organs and tissues in the control
and high-dose groups were examined.  Histopathological
examination was also extended to all tissues of the low- and
medium-dose groups if lesions were frequently found in the
high-dose group.
Immunohistochemistry
The avidin-biotin complex (ABC) method was used to
demonstrate alpha2u-globulin expression in the kidney.  After
deparaffinization, kidney sections were treated in a micro-
wave oven sequentially with 3% H2O2, normal rabbit serum,
goat polyclonal anti- alpha2u-globulin antibody (AF586,
R&D Systems, Inc., Minneapolis, MN, USA) diluted 1:300,
biotin-labeled secondary antibody and avidin-biotin complex
(Vectastain ABC kit, Funakoshi, Tokyo, Japan).  Tissue sec-
tions were lightly counterstained with hematoxylin.  Kidney
tissue sections without addition of primary antibody were used
as negative controls.  For positive controls, kidneys of rats
administered KBrO3, which is known to increase alpha2u-
globulin, were subjected to analysis.
Statistics
The Dunnett’s multiple range test was employed for
comparison of body weights, urinalysis, organ weights (both
absolute and relative), hematology and serum biochemistry
data between the control and treated groups.  For all compar-
isons, p-values less than 0.05 were considered to be statisti-
cally significant (Stat Light, Yukms Co., Ltd., Tokyo,
Japan).
Results
Clinical observations and survival
No deaths or obvious clinical signs were noted in any of
the animals throughout the experimental period.  During the
experiment, the body weights and cumulative body weight
gains in all treatment groups were similar to those of the con-
trols (Fig. 1).  The total intake of Equisetum arvense (g/rat)
for 13 weeks was 0 (0%), 3.8 (0.3%), 12.3 (1%) and 36.4
(3%) in males and 0 (0%), 2.3 (0.3%), 7.9 (1%) and 24.2
(3%) in females (Table 1).  There was no difference in food
consumption.
Table 1. Intake of Equisetum arvense during the Experiment
Food consumption Intake of Equisetum arvense Total intake of 
(g/rat/day) (g/rat/day) (g/kg BW/day) Equisetum arvense (g/rat)
Male Female Male Female Male Female Male Female
0% 13.4 8.6 – – – – – –
0.3% 14.0 8.5 0.04 0.03  0.18 0.17  3.78 2.30 
1% 13.6 8.8 0.14 0.09  0.59 0.60  12.28 7.94
3% 13.5 9.0  0.40 0.27  1.79 1.85  36.44 24.17Tago, Wei, Ishii et al. 247
Urinalysis
There were no significant differences in any of the
parameters among the groups, but the protein levels in the 1
and 3% male groups tended to decrease (Table 2).
Hematology and serum biochemistry
Significant alterations were observed in hematological
parameters (Table 3), including increased MCH in the 0.3%
males, increased PLT in the 1% females and decreased MCH
in the 1% females (p<0.05), but no dose dependence was
apparent.  In addition, a trend towards a dose-dependent
decrease in WBC was found in the females.  Data for serum
biochemistry are shown in Table 4.  There were significant
decreases in Ca in the 1 and 3% male groups (p<0.01 and
p<0.05) and in T-Cho in the 3% males (p<0.05).  A trend
Fig. 1. Body weight changes in F344 rats given Equisetum arvense. Symbols represent the means.
Fig. 2. Eosinophilic body with overexpression of alpha2u-globulin in the rat kidney.  Kidney sections from male control rats were used
to confirm whether eosinophilic bodies (arrowheads) were also positive for alpha2u-globulin. Some epithelial cells in proximal
tubules were positive. a: HE stain. b: immunohistochemistry for alpha2u-globulin. Scale bar shows 100 μm.
Fig. 3. Number of eosinophilic bodies in male rat kidneys.  No
significant differences were observed among the groups.  The
column and whisker represent the mean and standard
deviation, respectively.248 Evaluation of the Toxicity of Equisetum arvense in Rats
towards a dose-dependent decrease in TG was found in the
males.
Organ weights
Absolute and relative organ weights are summarized in
Table 5.  There were no significant differences in any organ
weights.  A tendency towards a decrease in the absolute
weights of the adrenals was observed in the males.
Macroscopic and microscopic findings
No treatment-related macroscopic changes were
observed in any of the animals at sacrifice.  Histopathologi-
cally, spontaneous inflammatory and proliferative lesions in
the liver and pancreas, microgranulomas in the liver, atrophy
in kidneys and cysts in the ovary and pituitary glands were
diagnosed.  All the changes were of minimal grade.  Eosino-
philic bodies and alpha2u-globulin expression in the proxi-
mal tubules of the kidneys were observed in all male rats,
including the 0% group (Fig. 2).  Extended microscopic
examination of kidneys in the 0.3 and 1% male groups
showed no histopathological changes compared with the 0%
group (Table 6).  The number of eosinophilic bodies per rat
among the groups was not significantly different (Fig. 3).
Moreover, no treatment-related findings were revealed in
Table 2. Urinalysis Data for F344 Rats Given Equisetum arvense
Sex Dose No. of  KET SG URO GLU PRO (mg/dl)
(%) rats – ± 1+ 2+ 3+ 1.015 1.020 1.025 1.030 0.1  1.0  – – ± 30 100
M a l e 0 1 0 0 13602 7 1 0641 00 1 1 8
0 . 3 1 0 0 01722 5 3 0731 00 0 3 7
1 1 0 0 05503 7 0 0911 01 0 7 2
3 1 0 0 02801 7 2 0731 00 0 7 3
F e m a l e 0 1 0 1 90002 6 2 0731 00 5 5 0
0 . 3 1 0 3 52006 4 0 0821 02 2 5 1
1 1 0 2 62005 3 1 1 1 0 01 00 4 6 0
3 1 0 3 61003 5 2 0821 02 5 3 0
pH OB NIT BIL
6.5 7.0  7.5  8.0  8.5  – ± 1+ 2+ – + – +
M a l e 0 1 0 0 0 0 0 1 0 5500 1 0 064
0 . 3 1 0 0 01097 1 2 0 1 0 0 7 3
1 1 0 0 01186 3 1 091 9 1
31 000 0 01 08 1 0 1 9 1 6 4
F e m a l e 0 1 0 0 0 0 0 1 0 1 0 000 1 0 055
0 . 3 1 0 0 0 0 0 1 0 9100 1 0 091
1 1 0 1 0 1 1 7 1 0 000 1 0 064
3 1 0 0 03078 2 0 0 1 0 0 7 3
Data show the numbers of rats for each value per parameter. Ketone (KET), specific gravity (SG), urobilinogen (URO), glucose (GLU), protein
(PRO), occult blood (OB), nitrite (NIH), bilirubin (BIL).
Table 3. Hematological Data for F344 Rats Given Equisetum arvense
Sex Dose No.  of  RBC  Hb Ht MCV MCH MCHC PLT WBC
(%) rats (×104/μL)  (g/dL)  (%)  (fL)  (pg)  (%) (×104/μL)  (/μL)
Male 0 10 894 ± 22 14.8 ± 0.5 47.6 ± 1.5 53.3 ± 0.9 16.5 ± 0.2 31.1 ± 0.4 55.9 ± 3.7 3460 ± 707
0.3 10 895 ± 17 15.0 ± 0.3 47.3 ± 0.8 52.9 ± 0.6 16.8 ± 0.2* 31.7 ± 0.4 54.9 ± 2.4 3650 ± 366
11 0 9 0 2 ± 26 14.9 ± 0.4 47.6 ± 1.0  52.7 ± 0.8 16.6 ± 0.1 31.4 ± 0.5 57.2 ± 3.4  3640 ± 881
31 0 9 0 1 ± 23 4.8 ± 0.4 47.2 ± 0.9 52.5 ± 1.1 16.5 ± 0.4 31.4 ± 0.8 53.1 ± 7.4 3460 ± 1237
Female 0 10 821 ± 21 15.1 ± 0.5 46.6 ± 1.7 56.8 ± 1.8 18.4 ± 0.5 32.3 ± 0.6 50.4 ± 7.4 3300 ± 1083
0.3 10 842 ± 21 15.4 ± 0.4 47.7 ± 1.3 56.7 ± 0.7 18.3 ± 0.1 32.4 ± 0.4 55.9 ± 4.5 3140 ± 986
11 0 8 3 5 ± 20 14.9 ± 0.3 46.2 ± 1.1 55.3 ± 0.9 17.9 ± 0.3*  32.3 ± 0.8 57.0 ± 4.3* 2970  ± 525
31 0 8 3 2 ± 35 14.9 ± 0.5 47.1 ± 2.2 56.4 ± 1.3 17.9 ± 0.4 31.6 ± 0.9 55.6 ± 5.0  2780 ± 627
Data are presented as the  means ± standard deviations.  * Significantly different from the control (0%) group (p<0.05).  Red blood cell count
(RBC), hemoglobin concentration (Hb), hematocrit (Ht), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean
corpuscular hemoglobin concentration (MCHC), platelet count (PLT), white blood cell count (WBC).Tago, Wei, Ishii et al. 249
Table 4. Serum Biochemistry Results for F344 Rats given Equisetum arvense
Sex Dose No. of  TP A/G ALB T-Bil T-Cho TG BUN CRN γ-GTP
(%) rats (g/dL)  (g/dL)  (mg/dL)  (mg/dL) (mg/dL)  (mg/dL) (mg/dL)  (IU/L)
Male 0 10 6.4 ± 0.1 2.4 ± 0.1 4.5 ± 0.1 0.1 ± 0 72 ± 69 1  ± 19 25 ± 40 . 3 0   ± 0.04 1.1 ± 0.3
0.3 10 6.4 ± 0.1 2.4 ± 0.1 4.5 ± 0.1 0.1 ± 0 71 ± 28 8  ± 20 25 ± 40 . 2 9   ± 0.02 1.3 ± 0.5
11 0 6 . 4   ± 0.2 2.4 ± 0.1 4.5 ± 0.1 0.1 ± 0 69 ± 48 5  ± 17 25 ± 40 . 2 9   ± 0.03 1.2 ± 0.6
31 0 6 . 4   ± 0.3 2.4 ± 0.2 4.5 ± 0.1 0.1 ± 06 5  ± 5* 81 ± 13 24 ± 50 . 2 8   ± 0.03 1.4 ± 1.0
Female 0 10 6.3 ± 0.1 2.8 ± 0.3 4.6 ± 0.2 0.1 ± 0 88 ± 65 0  ± 13 24 ± 5 0.29 ± 0.03 1.3 ± 0.5
0.3 10 6.2 ± 0.2 2.8 ± 0.2 4.6 ± 0.1 0.1 ± 0 92 ± 55 6  ± 19 23 ± 6 0.30 ± 0.03 1.1 ± 0.6
11 0 6 . 2   ± 0.2 2.8 ± 0.2 4.6 ± 0.1 0.1 ± 0 87 ± 73 9  ± 16 23 ± 7 0.28 ± 0.02 1.1 ± 0.3
31 0 6 . 1   ± 0.1 2.8 ± 0.2 4.5 ± 0.1 0.1 ± 0 85 ± 74 8  ± 12 23 ± 4 0.29 ± 0.03 1.0 ± 0.6
PN aC l K C a A S T A L T A L P
(mg/dL) (mEq/L) (mEq/L) (mEq/L) (mg/dL)  (IU/L) (IU/L) (IU/L)
Male 0 10 6.1 ± 0.4 146 ± 1 101 ± 14 . 3  ± 0.2 10.5 ± 0.2 130 ± 25 71 ± 7 461 ± 56
0.3 10 6.2 ± 0.5 146 ± 1 101 ± 14 . 4  ± 0.2 10.4 ± 0.3 145 ± 31 74 ± 11 470 ± 50
11 0 6 . 2   ± 0.5 146 ± 1 100 ± 14 . 4  ± 0.3 10.1 ± 0.1* 130 ± 19 66 ± 6 481 ± 50
31 0 6 . 5   ± 0.5 145 ± 1 100 ± 24 . 6  ± 0.5 10.2 ± 0.2* 143 ± 52 72 ± 10 462 ± 34
Female 0 10 4.8 ± 0.8 144 ± 1 102 ± 14 . 3  ± 0.4 9.8 ± 0.2 104 ± 11 43 ± 6 324 ± 47
0.3 10 4.9 ± 0.7 144 ± 2 102 ± 14 . 3  ± 0.4 9.8 ± 0.2 103 ± 12 42 ± 5 324 ± 66
11 0 4 . 8   ± 0.6 144 ± 1 102 ± 14 . 3  ± 0.3 9.6 ± 0.2 104 ± 84 2 ± 6 295 ± 51
3 10 5.0  ± 1.2 144 ± 1 102 ± 14 . 7  ± 0.8 9.8 ± 0.2 100 ± 12 42 ± 6 314 ± 40
Data are presented as mean ± SD.  * Significantly different from the control (0%) group (p<0.05).  Total proteins (TP), albumin/globulin ratio
(A/G), albumin (ALB), total bilirubin (T-Bil), total cholesterol (T-Cho), triglycerides (TG), blood urea nitrogen (BUN), creatinine (CRN), gamma
glutamyl transpeptidase (γ-GTP), inorganic phosphorus (P), sodium (Na), chloride (Cl), potassium (K), calcium (Ca), aspartate aminotransferase
(AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP).
Table 5. Organ Weights of F344 Rats Given Equisetum arvense
Sex Dose No. of 
 (%) rats Heart (g) Liver (g) Kidneys (g) Thymus (g)
Male 0 10 0.93 ± 0.05 (0.28) 7.34 ± 0.57 (2.24) 1.83 ± 0.17 (0.56) 0.24 ± 0.07 (0.07)
0.3 10 0.96 ± 0.05 (0.29) 7.72 ± 0.60 (2.29) 1.97 ± 0.12 (0.58) 0.27 ± 0.10 (0.08)
11 0 0 . 9 4   ± 0.06 (0.29) 7.36 ± 0.45 (2.26) 1.89 ± 0.10 (0.58) 0.21 ± 0.05 (0.06)
31 0 0 . 8 9   ± 0.06 (0.28) 7.03 ± 0.48 (2.22) 1.81 ± 0.05 (0.57) 0.21 ± 0.06 (0.07)
Female 0 10 0.59 ± 0.03 (0.33) 3.75 ± 0.23 (2.12) 1.13 ± 0.10 (0.64) 0.17 ± 0.03 (0.10)
0.3 10 0.59 ± 0.04 (0.34) 3.74 ± 0.17 (2.11) 1.14 ± 0.07 (0.64) 0.18 ± 0.03 (0.10)
11 0 0 . 5 9   ± 0.05 (0.34) 3.71 ± 0.23 (2.09) 1.14 ± 0.09 (0.64) 0.18 ± 0.04 (0.10)
31 0 0 . 6 0   ± 0.04 (0.34) 3.83 ± 0.39 (2.18) 1.17 ± 0.07 (0.67) 0.17 ± 0.02 (0.10)
Brain (g) Adrenals (g) Spleen (g) Testes (g)
Male 0 10 1.97 ± 0.07 (0.60) 0.043 ± 0.012 (0.013) 0.66 ± 0.04 (0.20) 3.10 ± 0.16 (0.95)
0.3 10 1.97 ± 0.07 (0.58) 0.040 ± 0.007 (0.012) 0.65 ± 0.03 (0.19) 3.07 ± 0.12 (0.91)
11 0 1 . 9 9   ± 0.03 (0.61) 0.039 ± 0.012 (0.012) 0.63 ± 0.03 (0.19) 3.03 ± 0.17 (0.93)
31 0 1 . 9 6   ± 0.04 (0.62) 0.034 ± 0.007 (0.011) 0.63 ± 0.03 (0.20) 3.06 ± 0.11 (0.97)
Female 0 10 1.81 ± 0.04 (1.03) 0.041 ± 0.007 (0.023) 0.40 ± 0.02 (0.23) –
0.3 10 1.80 ± 0.06 (1.02) 0.041 ± 0.006 (0.023) 0.40 ± 0.02 (0.23) –
11 0 1 . 8 3   ± 0.06 (1.04) 0.039 ± 0.008 (0.022) 0.40 ± 0.04 (0.23) –
31 0 1 . 8 0   ± 0.04 (1.03) 0.040 ± 0.004 (0.023) 0.41 ± 0.06 (0.23) –
Data are presented as the means ± standard deviations.  Values in parentheses show the mean relative organ weights.250 Evaluation of the Toxicity of Equisetum arvense in Rats
other tissues and organs of the male or female rats.
Discussion
In the present study, dietary administration with Equi-
setum arvense for 13 weeks was not found to alter body
weight in either gender of rat.  The decline of the urine pro-
tein levels after administration of Equisetum arvense in the 1
and 3% male groups may be related to its diuretic effect,
which was previously reported6.  Although the WBC in
females and the weights of the adrenals in males were dose-
dependently decreased, no histopathological changes related
to inflammation and atrophy of adrenals were observed.
Furthermore, although a significant decrease in the concen-
tration of serum Ca was noted in the 1 and 3% groups in
males, all values were within the physiological range previ-
ously observed in our lab.  A significant decrease in T-Cho
and a tendency for decrease in TG were seen in a dose-
related manner in males, but no histopathological changes
pointing to altered lipid metabolism were observed in the
liver.
Histopathological examination of kidneys revealed the
existence of intracytoplasmic granules, diagnosed as eosino-
philic bodies, seen in the proximal tubules in all male groups
(Fig. 2a), but not in the female rats.  These granules were
demonstrated to be alpha2u-globulin by immunohistochem-
istry (Fig. 2b).  Abnormal accumulation of alpha2u-globulin
is known to be related to nephropathy and renal carcinogen-
esis in male rats9, 10.  As no difference in the number of eosi-
nophilic bodies was seen between the control and treated
groups, administration of Equisetum arvense clearly exerted
no effects on the formation of alpha2u-globulin.
In an earlier toxicological report for rats11, dietary
administration of 4% Equisetum arvense with 0.5%
cholesterol and 0.15% sodium cholate for 14 days caused
dermatitis of the neck, head and back skin in about 20-65%
of rats, with no significant differences in the serum IgE lev-
els.  However, clinical signs, such as redness and edema,
were not observed in this 13-week dietary administration
study.  Therefore, it is likely that Equisetum arvense alone
does not induce dermatitis in rats and that the changes
observed in the earlier study were probably due to coadmin-
stration of excess amounts of cholesterol and/or sodium
cholate with Equisetum arvense11.
In humans, it was reported that seborrhoeic dermatitis
occurred in some patients, transdermal absorption of Equise-
tum arvense after passive inhalation of tobacco smoke8.
Smoke components, such as nicotine and formaldehyde are
considered to cause allergic contact dermatitis12. 
However, the results of the present study showed no
adverse effects of Equisetum arvense when administered
alone in diet.  Taking into accounts these reports, we predict
that additional factors such as a potential allergen of tobacco
might influence the side effects of Equisetum arvense. 
In conclusion, we determined the no-observed-adverse-
effect level (NOAEL) for Equisetum arvense to be more than
3% in both male and female rats (males and females: >1.79
g/kg BW/day and >1.85 g/kg BW/day, respectively) under
the conditions of the present study. 
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